Company Felix acquires notable stake from Advent
In a significant move for the global animal pharmaceutical industry, Advent International, a renowned global private equity investor, has agreed to acquire a substantial minority stake in Felix Pharmaceuticals Pvt Ltd, a leading player in Gx animal pharma.
The acquisition was advised by a team of experts, with Michael Coyle leading the Corporate and M&A division. Tim Gleeson, Daire Cassidy, Glyn McCormack, and Sondos Siddiqi were also part of the team. However, the key legal advisor for Felix Pharmaceuticals was identified as Sidharrth Shankar, Partner at JSA, who led the legal advisory team for Felix Pharmaceuticals, supported by his colleagues at JSA.
While Advent International's core deal team members have not been publicly named, the company is known for deploying a broad team of investment and operating professionals. These unnamed individuals likely contributed to the successful negotiation and execution of the deal.
In the Life Sciences aspect of the deal, Colin Kavanagh played a crucial role. Meanwhile, Simon Breen and Robert Byrne were part of the Competition and Regulated Markets team, ensuring compliance with relevant regulations. David Kilty and Nicola Cavey were involved in the Tax aspects of the deal, ensuring a favourable financial outcome for both parties.
For more information about Advent International, visitors are encouraged to explore the company's website, which provides comprehensive details about their operations and investments. This acquisition marks another strategic move for Advent International, further cementing their position as a key player in the global private equity market.
- This acquisition marks another strategic move for Advent International, further asserting their prominence in the global private equity market, where they primarily operate in finance.
- The successful negotiation and execution of the deal was aided by Advent International's broad team of investment and operating professionals, comprised of experts in various financial sectors, including private equity.
